Terazosin
Sponsors
Thomas Jefferson University, Anhui Medical University, University of Washington, Capital Medical University, Cedars-Sinai Medical Center
Conditions
Antidepressant Induced Excessive SweatingCardiovascular EffectsCarotid Artery StenosisGait AnalysisHealthyHyperhidrosisHypertensionLower Urinary Tract Symptoms
Phase 1
Phase 2
Safety and Efficacy of Low Dosage of Terazosin in Subjects Undergoing Carotid Artery Stenting
NCT03195673
Start: 2018-03-02End: 2019-12-15Target: 160Updated: 2018-12-11
Terazosin Effect on Cardiac Changes in Early Parkinson's Disease
Active, not recruitingNCT04386317
Start: 2020-11-01End: 2026-03-10Target: 15Updated: 2026-03-02
Phase 3
Phase 4
Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Terazosin
CompletedNCT00449683
Start: 2007-03-31End: 2013-08-31Updated: 2016-08-25
Motor Function Efficacy of Pharmacological Treatments Targeting Energy Metabolism, in Parkinson's Patients
Not yet recruitingNCT05855577
Start: 2023-12-31End: 2026-05-31Target: 50Updated: 2023-09-22
Unknown Phase
Pilot Study of Terazosin in Treatment of Antidepressant Induced Excessive Sweating
CompletedNCT00237510
Start: 2005-05-31End: 2007-05-31Target: 15Updated: 2014-03-05
Effect of Amlodipine Monotherapy or Combined With Terazosin on Lower Urinary Tract Symptoms and Hypertension
CompletedNCT00693199
Start: 2006-07-31End: 2006-10-31Updated: 2008-08-08
Diesel Exhaust and Vascular Function
NCT01508637
Start: 2012-01-31End: 2015-12-31Target: 24Updated: 2015-08-03